Startseite › Morbus Crohn › Florida › Miami
Klinische Studien zu Morbus Crohn in Miami, FL
19 Studien zu Morbus Crohn suchen Teilnehmer an Standorten in und um Miami (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Teilnehmer gesuchtPhase 3
- Sanchez Clinical Research ( Site 5144), Miami
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Teilnehmer gesuchtPhase 2
- Research Associates of South Florida /ID# 280929, Miami
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Teilnehmer gesuchtPhase 4
- Gastro Health Research - Miami, Miami
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Teilnehmer gesuchtPhase 2
- A Plus Research /ID# 265878, Miami
- Sanchez Clinical Research /ID# 265887, Miami
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 3
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 2/3
- Sanchez Clinical Research, Inc, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Teilnehmer gesucht
- University of Miami, Miami
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 3
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Regis Clinical Research, LLC-Site Number: 8400041, Miami
- Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111, Miami
- und 4 weitere
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 3
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 2
- Bioresearch Partner-Kendale Lakes, Miami
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Teilnehmer gesuchtPhase 2
- Gastro Health Research - Miami, Miami
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Teilnehmer gesuchtPhase 2
- Gastro Health Research - Miami, Miami
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 3
- Sanchez Clinical Research, Inc, Miami
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Teilnehmer gesuchtBeobachtungsstudie
- University of Miami, Miami
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Teilnehmer gesuchtPhase 2
- Research Associates of South Florida, LLC, Miami
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Teilnehmer gesuchtPhase 4
- University of Miami, Miami
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Teilnehmer gesuchtPhase 2
- Investigational Site Number 8400028, Miami
- Investigational Site Number: 8400012, Miami
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Teilnehmer gesuchtPhase 2
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
Morbus Crohn-Studien in anderen Städten
- New York City, NY35 Studien
- Cleveland, OH19 Studien
- St. Louis, MO19 Studien
- Boston, MA19 Studien
- Orlando, FL17 Studien
- Houston, TX17 Studien
- Atlanta, GA17 Studien
- Tyler, TX16 Studien
- San Diego, CA15 Studien
- San Antonio, TX15 Studien
- Los Angeles, CA15 Studien
- Philadelphia, PA13 Studien
Weitere Studien in Miami
- Brustkrebs42 Studien
- Krebs (alle Arten)36 Studien
- Nichtkleinzelliges Lungenkarzinom31 Studien
- Prostatakrebs27 Studien
- Adipositas27 Studien
- Akute myeloische Leukämie24 Studien
- Metastasierender Krebs24 Studien
- Eierstockkrebs23 Studien
- Übergewicht23 Studien
- Multiples Myelom21 Studien
- Colitis ulcerosa21 Studien
- Alzheimer-Krankheit20 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.